Although inflammasome-mediated pyroptosis in glioma has not been reported, IL1β has been shown to be a serum marker in glioblastoma [16, 17], which prompted us to explore potential pyroptosis pathways in glioma. This evidence concerns the gene IL1B and central nervous system cancer.